Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IgG4 serum levels in Graves' orbitopathy.
Comi S, Lanzolla G, Cosentino G, Maglionico MN, Posarelli C, Menconi F, Santini F, Elisei R, Marinò M. Comi S, et al. Among authors: menconi f. J Endocrinol Invest. 2023 Dec 21. doi: 10.1007/s40618-023-02265-3. Online ahead of print. J Endocrinol Invest. 2023. PMID: 38127192
Absence of a relationship between vitamin D and Graves' orbitopathy.
Lanzolla G, Di Matteo L, Comi S, Cosentino G, Menconi F, Maglionico MN, Posarelli C, Figus M, Marinò M. Lanzolla G, et al. Among authors: menconi f. J Endocrinol Invest. 2023 Aug;46(8):1717-1721. doi: 10.1007/s40618-023-02017-3. Epub 2023 Jan 25. J Endocrinol Invest. 2023. PMID: 36696067 No abstract available.
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy.
Lanzolla G, Puccinelli L, Giudetti M, Comi S, Menconi F, Maglionico MN, Posarelli C, Figus M, Marcocci C, Marinò M. Lanzolla G, et al. Among authors: menconi f. J Endocrinol Invest. 2023 Feb;46(2):337-344. doi: 10.1007/s40618-022-01906-3. Epub 2022 Aug 27. J Endocrinol Invest. 2023. PMID: 36030301 Free PMC article.
Sirolimus as a second-line treatment for Graves' orbitopathy.
Lanzolla G, Maglionico MN, Comi S, Menconi F, Piaggi P, Posarelli C, Figus M, Marcocci C, Marinò M. Lanzolla G, et al. Among authors: menconi f. J Endocrinol Invest. 2022 Nov;45(11):2171-2180. doi: 10.1007/s40618-022-01862-y. Epub 2022 Jul 13. J Endocrinol Invest. 2022. PMID: 35831587 Free PMC article.
Functional outcomes and complications in refractory dysthyroid optic neuropathy management: Experience with 3 different surgical protocols.
Dallan I, Cristofani-Mencacci L, Fiacchini G, Benettini G, Picariello M, Lanzolla G, Lazzerini F, Rocchi R, Turri-Zanoni M, Menconi F, Sellari-Franceschini S, Marinò M. Dallan I, et al. Among authors: menconi f. Am J Otolaryngol. 2022 May-Jun;43(3):103451. doi: 10.1016/j.amjoto.2022.103451. Epub 2022 Apr 11. Am J Otolaryngol. 2022. PMID: 35439657
Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO): results of a large cohort study.
Rotondo Dottore G, Torregrossa L, Lanzolla G, Mariotti S, Menconi F, Piaggi P, Cristofani Mencacci L, Posarelli C, Maglionico MN, Dallan I, Figus M, Nardi M, Marcocci C, Basolo F, Marinò M. Rotondo Dottore G, et al. Among authors: menconi f. J Endocrinol Invest. 2022 Mar;45(3):563-572. doi: 10.1007/s40618-021-01692-4. Epub 2021 Oct 21. J Endocrinol Invest. 2022. PMID: 34671950
63 results